智通财经APP讯,多瑞医药(301075.SZ)发布公告,根据公司经营及战略发展的需要,为优化公司总部管理职能,公司成立全资子公司西藏瑞升祥医药有限公司,注册资本200万元。
智通财经APP讯,多瑞医药(301075.SZ)发布公告,根据公司经营及战略发展的需要,为优化公司总部管理职能,公司成立全资子公司西藏瑞升祥医药有限公司,注册资本200万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.